Skip to content

Severe Combined Immunodeficiency Autosomal Recessive T Cell Negative B Cell Negative Nk Cell Positive C1832322

Published: July 22, 2026Updated: August 20, 2026

This rare autosomal recessive SCID affects T cell development while preserving NK cells. Without functioning T cells, affected infants experience life-threatening infections early in life. Early hematopoietic stem cell transplantation offers the best chance for survival.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe viral respiratory infections

!

Severe disseminated BCG infection

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Failure to thrive

(gastrointestinal)

Persistent lymphopenia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hematopoietic Stem Cell Transplantation (HSCT)

Definitive curative treatment using healthy donor stem cells to重建 functional T and B lymphocyte populations. Early intervention before infections occur significantly improves survival rates exceeding 90%.

procedure
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Antimicrobial Prophylaxis Regimen

Combination prophylactic antibiotics and antifungals to prevent opportunistic infections during immune compromise. Typically includes TMP-SMX, azithromycin, and fluconazole.

medication

Additional treatment options

Intravenous Immunoglobulin (IVIG) Therapy

Regular immunoglobulin replacement therapy provides essential antibody coverage in the absence of functional B cells. Dosing individualized based on weight and IgG levels.

medication

Dietary and Nutritional Support

Enhanced nutritional support including micronutrient supplementation to support immune function and growth. May require specialized formulas or tube feeding if oral intake is insufficient.

lifestyle

Comprehensive Immune Monitoring

Regular laboratory monitoring of lymphocyte subsets, immunoglobulin levels, and T-cell function assays to track immune recovery and guide treatment decisions post-transplant.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Severe Combined Immunodeficiency Autosomal Recessive T Cell Negative B Cell Negative Nk Cell Positive C1832322?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Shearer WT, Dunn E, Notarangelo LD, et al. Establishing diagnostic criteria for severe combined immunodeficiency disease. J Clin Immunol. 2014.

guideline2014
2

Fischer A, Revy P, Le Deist F. Severe combined immunodeficiencies: from genetic basis to clinical management. Immunol Rev. 2019.

review2019
3

Haddad E, Hoenig M, Neven B, et al. Hematopoietic stem cell transplantation for autosomal recessive T-B-NK+ severe combined immunodeficiency. Blood Adv. 2021.

clinical_trial2021
4

Cassano B, Puck J, Schwartz G. Genetic heterogeneity in T-B-NK+ severe combined immunodeficiency. Clin Immunol. 2022.

review2022

Medication Comparisons

Compare medications used to treat Severe Combined Immunodeficiency Autosomal Recessive T Cell Negative B Cell Negative Nk Cell Positive C1832322. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy